About the Book
Source: Wikia. Pages: 62. Chapters: Absorption, Basal, Blood sugar guidelines, Bolus, Booster, Carbohydrates, Carryover, Cartridge, Combining insulin, Counterregulatory hormones, Curve, Dawn phenomenon, Depot insulin, Diabetes, Dosage abbreviation, Duration, Endocrinopathy, Endogenous, Euglycemia, Exogenous, Fasting, Fatty liver, Fructosamine, Gastroparesis, Gestational diabetes, Glucagon, Glucometer, Gluconeogenesis, Glucose toxicity, Glycogen, Glycogenolysis, Glycosuria, Hometesting blood glucose, Hyperglycemia, Hyperlipidemia, Hypoglycemia, Insulin depot, Insulin pen, Insulin resistance, Insulin sensitivity, Intravenously, Ketoacidosis, Lethargy, Lipodystrophy, Lipohypertrophy, Mini-curve, NPH, Nephropathy, Neuropathy, OTC, Off label, Onset, Oral medication, Overlap, PZI, Pancreas, Peak, Pharmacokinetics, Polydipsia, Polyphagia, Polyuria, Post-prandial, Preservatives, Protamine, R, Remission, Renal threshold, Replacement therapy, Rolling insulin, Secondary diabetes, Semilente, Soluble insulin, Somogyi rebound, Subcutaneously, Suspension, Syringe, Taurine, Tight regulation, Transient diabetes, Triglycerides, Ultralente, Urine testing stix, Variability. Excerpt: After you inject insulin, it goes into the bloodstream to work. If the insulin is R/neutral or one of the non-mixed analogs, it will be absorbed quickly. Fast-acting insulins are designed to be absorbed even faster, while insulin suspensions are made to "hinder" the rapid absorption of the insulin, to make them work for a longer time period. The importance of how insulin is absorbed after it is injected under the skin is illustrated in this 2002 ADA Diabetes Care study, where Short-acting R/Neutral and Long-acting Lantus were compared when given intravenously, as opposed to subcutaneous use. Researchers found nothing slow-acting about Lantus when it was given intravenously, and they concluded that it is the absorption process from beneath the skin which produces the quite different effects these two hav...
